120 related articles for article (PubMed ID: 27341601)
21. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
[TBL] [Abstract][Full Text] [Related]
23. GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.
Cotte E; Villeneuve L; Passot G; Boschetti G; Bin-Dorel S; Francois Y; Glehen O;
BMC Cancer; 2015 Feb; 15():47. PubMed ID: 25849254
[TBL] [Abstract][Full Text] [Related]
24. Unique considerations in the patient with rectal cancer.
Minsky BD
Semin Oncol; 2011 Aug; 38(4):542-51. PubMed ID: 21810513
[TBL] [Abstract][Full Text] [Related]
25. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
27. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
Crane CH; Skibber JM; Feig BW; Vauthey JN; Thames HD; Curley SA; Rodriguez-Bigas MA; Wolff RA; Ellis LM; Delclos ME; Lin EH; Janjan NA
Cancer; 2003 Jan; 97(2):517-24. PubMed ID: 12518377
[TBL] [Abstract][Full Text] [Related]
28. Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?
Weiss J; Moghanaki D; Plastaras JP; Haller DG
Clin Colorectal Cancer; 2009 Oct; 8(4):194-9. PubMed ID: 19822509
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy for rectal cancer: results and controversies.
Minsky BD
Oncology (Williston Park); 1998 Aug; 12(8):1129-39; discussion 1143-6. PubMed ID: 11236307
[TBL] [Abstract][Full Text] [Related]
30. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
31. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy of rectal cancer.
Minsky BD
Semin Oncol; 1999 Oct; 26(5):540-4. PubMed ID: 10528902
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant treatment for rectal cancer: current status.
Schneebaum S; Arnold MW; Martin EW
Oncology (Williston Park); 1993 Mar; 7(3):83-90, 93; discussion 93-4, 97-101. PubMed ID: 8452782
[TBL] [Abstract][Full Text] [Related]
35. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection.
Lim SB; Yu CS; Hong YS; Kim TW; Kim JH; Kim JC
J Surg Oncol; 2012 Nov; 106(6):659-66. PubMed ID: 22674581
[TBL] [Abstract][Full Text] [Related]
37. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative radiochemotherapy of rectal carcinoma. Current status].
Rau B; Wust P; Riess H; Schlag PM
Zentralbl Chir; 2000; 125(4):356-64. PubMed ID: 10829316
[TBL] [Abstract][Full Text] [Related]
39. Rectal cancer. Treatment advances that reduce recurrence rates and lengthen survival.
Sexe R; Miedema BW
Postgrad Med; 1993 Jul; 94(1):183-90, 193. PubMed ID: 8321771
[TBL] [Abstract][Full Text] [Related]
40. Advances and challenges in treatment of locally advanced rectal cancer.
Smith JJ; Garcia-Aguilar J
J Clin Oncol; 2015 Jun; 33(16):1797-808. PubMed ID: 25918296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
